Bleichroeder LP’s Evoke Pharma EVOK Stock Holding History

Bleichroeder LP’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-146,395	Closed	-$728K	–	76
2025 Q3	$728K	Buy	146,395 +77,645	+113%	+$385K	0.14%	39
2025 Q2	$179K	Hold	68,750	–	–	0.04%	56
2025 Q1	$189K	Hold	68,750	–	–	0.05%	57
2024 Q4	$304K	Hold	68,750	–	–	0.08%	47
2024 Q3	$327K	Hold	68,750	–	–	0.09%	45
2024 Q2	$436K	Hold	68,750	–	–	0.13%	41
2024 Q1	$503K	Buy	+68,750	New	+$584K	0.13%	41

Bleichroeder LP's EVOK Position: Q4 2025 in Review

Bleichroeder LP sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 146,395 shares — an estimated $728K sold.

Bleichroeder LP first reported a position in EVOK in Q1 2024 and held it in 7 quarters. The position peaked at $728K in Q3 2025. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.

Bleichroeder LP reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
Bleichroeder LP sold 146,395 Evoke Pharma shares in Q4 2025, an estimated $728K.
Bleichroeder LP first reported a position in Evoke Pharma in Q1 2024 and held it in 7 quarters.
Bleichroeder LP's Evoke Pharma position peaked at $728K in Q3 2025.
0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.

Based on Bleichroeder LP's 13F filing for Q4 2025, filed 13 Feb 2026.